Correlation Between Citigroup and Cymabay Therapeu
Can any of the company-specific risk be diversified away by investing in both Citigroup and Cymabay Therapeu at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citigroup and Cymabay Therapeu into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citigroup and Cymabay Therapeu, you can compare the effects of market volatilities on Citigroup and Cymabay Therapeu and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of Cymabay Therapeu. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and Cymabay Therapeu.
Diversification Opportunities for Citigroup and Cymabay Therapeu
-0.16 | Correlation Coefficient |
Good diversification
The 3 months correlation between Citigroup and Cymabay is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and Cymabay Therapeu in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cymabay Therapeu and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with Cymabay Therapeu. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cymabay Therapeu has no effect on the direction of Citigroup i.e., Citigroup and Cymabay Therapeu go up and down completely randomly.
Pair Corralation between Citigroup and Cymabay Therapeu
If you would invest 7,250 in Citigroup on October 11, 2024 and sell it today you would earn a total of 76.00 from holding Citigroup or generate 1.05% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 4.76% |
Values | Daily Returns |
Citigroup vs. Cymabay Therapeu
Performance |
Timeline |
Citigroup |
Cymabay Therapeu |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Citigroup and Cymabay Therapeu Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Citigroup and Cymabay Therapeu
The main advantage of trading using opposite Citigroup and Cymabay Therapeu positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, Cymabay Therapeu can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cymabay Therapeu will offset losses from the drop in Cymabay Therapeu's long position.Citigroup vs. Royal Bank of | Citigroup vs. JPMorgan Chase Co | Citigroup vs. Nu Holdings | Citigroup vs. Canadian Imperial Bank |
Cymabay Therapeu vs. Day One Biopharmaceuticals | Cymabay Therapeu vs. X4 Pharmaceuticals | Cymabay Therapeu vs. Inozyme Pharma | Cymabay Therapeu vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |